고지혈증 치료제 시장 분석 및 예측(-2034년) : 유형별, 제품별, 용도별, 최종 사용자별, 기술별, 형태별, 프로세스별, 기능별, 솔루션별

Antihyperlipidemic Drugs Market Analysis and Forecast to 2034: Type, Product, Application, End User, Technology, Form, Process, Functionality, Solutions

US $ 4,750 ￦ 7,047,000

PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.

US $ 5,750 ￦ 8,531,000

PDF & Excel (Site License)

PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.

US $ 6,750 ￦ 10,014,000

PDF & Excel (Enterprise License)

PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.

한글목차

고지혈증 치료제 시장은 2024년 133억 달러에서 2034년까지 184억 달러로 확대되어 CAGR 약 3.6%를 나타낼 것으로 예측됩니다. 고지혈증 치료제 시장은 심혈관 위험 관리에 필수적인 혈중 지질 수준을 낮추기 위한 의약품을 포함합니다. 이러한 약제는 스타틴, 피브레이트, 니아신, PCSK9 억제제 등을 포함하며, 고콜레스테롤혈증과 고중성지방혈증 등의 상태를 표적으로 하고 있습니다. 시장 성장은 심혈관 질환의 유병률 상승, 노인 인구 증가, 약물 제형의 진보에 의해 추진되고 있습니다. 맞춤형 의료 및 병용 요법에 중점을 두어 효과적인 지질 관리와 환자의 복약 준수를 촉진하여 시장 상황을 더욱 풍요롭게 합니다.

고지혈증 치료제 시장은 콜레스테롤 관련 건강 우려 증가와 건강 관리 의식 향상으로 견조한 성장을 이루고 있습니다. 스타틴계 약제는 LDL 콜레스테롤 수치 감소에서 입증된 효능으로부터 시장을 독점하는 최상위 부위입니다. 이에 이어 PCSK9 억제제는 기존 요법에 저항성이 있는 환자에게 효과를 주목하고 있습니다. Fibrato 부문은 특히 높은 triglyceride 혈증 환자에서 유망한 성장을 보여줍니다. 비스타틴계 요법에서는 담즙산 흡착제와 콜레스테롤 흡수 억제제가 종합적인 지질 관리 전략에서의 역할을 반영하여 점차 채용이 진행되고 있습니다. 영양 보충제 하위 부문은 자연스럽고 예방적인 건강 관리 솔루션을 추구하는 소비자의 선호도에 힘입어 유력한 대안으로 부상하고 있습니다. 복합 요법은 지질 통제를 강화하고 환자 컴플라이언스를 향상시켜 점점 보급되고 있습니다. 지속적인 R&D 투자는 혁신적인 약물 제형 및 전달 메커니즘의 개발을 추진하고 시장의 지속적인 기세를 확보함으로써 시장을 더욱 강화하고 있습니다.

시장 세분화
유형	스타틴, 담즙산 흡착제, 콜레스테롤 흡수 억제제, 피브릭산 약제, PCSK9 억제제, 니코틴산, 오메가 3 지방산 유도체
제품	정제, 캡슐, 주사제, 분말
적응증	고콜레스테롤혈증, 고중성지방혈증, 혼합형 이상지질혈증, 가족성 고콜레스테롤혈증, 죽상경화성 심혈관 질환
최종 사용자	병원, 진료소, 재택치료 시설, 학술 및 연구 기관
기술	생명공학, 합성화학, 나노기술
형태	즉방형, 서방형
프로세스	연구개발, 제조, 유통
기능성	지질저하, 항염증, 심장 보호
솔루션	환자 모니터링, 약물 관리

고지혈증 치료제 시장은 확립된 제약 대기업이 주도하는 다양한 시장 점유율 분포가 특징입니다. 가격 전략은 제네릭 의약품의 도입과 혁신적인 제제의 영향을 받아 경쟁이 계속되고 있습니다. 효과적인 지질저하요법에 대한 수요 증가에 대응하기 위해 각사가 연구개발에 투자하는 가운데 신제품의 발매가 시장을 계속 활성화하고 있습니다. 제품 포트폴리오를 확대하고 시장 존재를 강화하기 위한 전략적 제휴와 합병은 시장의 역동적인 성질을 더욱 강조하고 있습니다. 경쟁 벤치마킹에서는 소수의 주요 기업이 시장을 독점하는 구도가 분명하고, 신흥 기업이 현재 과제를 계속하고 있습니다. 규제의 영향은 매우 중요하며 엄격한 지침과 승인 프로세스가 시장 진입과 제품 수명주기에 영향을 미칩니다. 시장에서는 맞춤형 의료로의 전환이 진행되고 환자에 맞는 치료 계획이 중시되고 있습니다. 이러한 추세는 생명공학과 유전체학의 발전에 의해 지원되고 있으며, 향후 성장을 이끌 것으로 기대됩니다. 규제 프레임 워크와 혁신의 상호 작용은 시장의 경쟁 구도를 계속 형성하고 있습니다.

고지혈증 치료제 시장은 세계적인 관세, 지정 학적 위험 및 변화하는 공급망의 동향에 크게 영향을 받고 있습니다. 일본과 한국에서는 수입 의약품 원료에 대한 의존도가 높아 무역 마찰이 높아짐에 따라 국내 생산 능력 강화를 위한 전략적 전환을 촉진하고 있습니다. 중국은 혁신과 자급자족에 의한 의약품 산업의 강화에 주력하는 한편, 대만은 지정학적 마찰의 영향을 받기 쉬운 것, 의약품 제조에 있어서 중요한 역할을 유지하고 있습니다. 부모시장에서는 심혈관질환의 유병률 상승과 의료비 지출 증가를 배경으로 견조한 성장을 이루고 있습니다. 2035년까지 전략적 제휴와 기술 진보를 통해 시장 확대가 예상됩니다. 중동 분쟁은 공급망의 혼란과 에너지 가격의 변동을 악화시키고 간접적으로 생산 비용과 시장 안정성에 영향을 미칩니다.

주요 동향과 성장 촉진요인 :

고지혈증 치료제 시장은 세계적인 고령화와 심혈관 질환 증가를 배경으로 견조한 성장을 이루고 있습니다. 주요 동향은 치료 효과와 환자 컴플라이언스를 향상시키는 병용 요법의 도입 증가를 포함합니다. 또한 생물학적 이용능력의 향상과 부작용 경감을 목적으로 한 신규 약물전달 시스템의 개발도 진전하고 있습니다. 게다가, 개인화된 의료의 상승은 개인의 유전자 프로파일에 맞는 치료 프로토콜에 영향을 미칩니다. 생활 습관으로 인한 고지혈증에 대한 인식 증가는 효과적인 관리 솔루션에 대한 수요를 추진하고 있으며, 의료 서비스 제공업체는 예방 의료에 주력하고 있습니다. 신약 개발 개발 기술의 발전에 의해 혁신적인 항고지혈증제의 도입이 가속화되고 있습니다. 게다가 신흥국의 헬스케어 인프라의 확충이 시장 확대의 새로운 기회를 창출하고 있습니다. 비용효과가 뛰어난 강력한 약제 개발을 위한 연구개발에 투자하는 기업은 큰 시장 점유율을 획득하는 태세를 갖추고 있습니다. 또한 세계적인 심혈관 질환의 부담 경감을 목표로 하는 정부 주도의 대처 증가도 본 시장에 몰입하고 있습니다.

목차

제1장 고지혈증 치료제 시장 개요

• 조사 목적
• 고지혈증 치료제 시장 : 보고서의 정의와 조사 범위
• 보고서의 제한 사항
• 조사 대상 기간 및 통화
• 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 고지혈증 치료제 시장 전망

• 고지혈증 치료제 시장 세분화
• 시장 역학
• Porter's Five Forces 분석
• PESTEL 분석
• 밸류체인 분석
• 4P 모델
• ANSOFF 매트릭스

제5장 고지혈증 치료제 시장 전략

• 상위 시장 분석
• 수급 분석
• 소비자의 구매 의욕
• 사례 연구 분석
• 가격 분석
• 규제 상황
• 공급망 분석
• 경쟁 제품 분석
• 최근 동향

제6장 고지혈증 치료제 시장 규모

• 고지혈증 치료제 시장 규모(금액 기준)
• 고지혈증 치료제 시장 규모(수량 기준)

제7장 고지혈증 치료제 시장 : 유형별

• 스타틴
• 담즙산 흡착제
• 콜레스테롤 흡수 억제제
• 피브릭산 유도체
• PCSK9 억제제
• 니코틴산
• 오메가 3 지방산 유도체
• 기타

제8장 고지혈증 치료제 시장 : 제품별

• 정체
• 캡슐
• 주사제
• 분말
• 기타

제9장 고지혈증 치료제 시장 : 용도별

• 고콜레스테롤혈증
• 고중성지방혈증
• 혼합형 이상지질혈증
• 가족성 고콜레스테롤혈증
• 죽상경화성 심혈관 질환
• 기타

제10장 고지혈증 치료제 시장 : 최종 사용자별

• 병원
• 진료소
• 재택치료 시설
• 학술 및 연구 기관
• 기타

제11장 고지혈증 치료제 시장 : 기술별

• 생명공학
• 합성화학
• 나노기술
• 기타

제12장 고지혈증 치료제 시장 : 폼별

• 즉방형
• 서방형
• 기타

제13장 고지혈증 치료제 시장 : 프로세스별

• 연구개발
• 제조
• 유통
• 기타

제14장 고지혈증 치료제 시장 : 기능별

• 지질 저하
• 항염증
• 심장 보호
• 기타

제15장 고지혈증 치료제 시장 : 솔루션별

• 환자 모니터링
• 약물 관리
• 기타

제16장 고지혈증 치료제 시장 : 지역별

• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 스페인
  • 이탈리아
  • 네덜란드
  • 스웨덴
  • 스위스
  • 덴마크
  • 핀란드
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주
  • 싱가포르
  • 인도네시아
  • 대만
  • 말레이시아
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카
  • 기타 중동 및 아프리카

제17장 경쟁 구도

• 시장 점유율 분석
• 주요 기업의 포지셔닝
• 경쟁 리더십 매핑
• 공급업체 벤치마킹
• 개발 전략 벤치마킹

제18장 기업 프로파일

• Amarin
• Esperion Therapeutics
• Chiesi Farmaceutici
• Nippon Chemiphar
• Kowa Pharmaceuticals
• Recordati
• Daiichi Sankyo
• Zydus Cadila
• Torrent Pharmaceuticals
• Lupin Pharmaceuticals
• Dr. Reddy's Laboratories
• Sun Pharmaceutical Industries
• Cipla
• Aurobindo Pharma
• Glenmark Pharmaceuticals
• Alkem Laboratories
• Biocon
• Alnylam Pharmaceuticals
• Arrowhead Pharmaceuticals
• Ionis Pharmaceuticals

KTH

영문 목차

영문목차

Antihyperlipidemic Drugs Market is anticipated to expand from $13.3 billion in 2024 to $18.4 billion by 2034, growing at a CAGR of approximately 3.6%. The Antihyperlipidemic Drugs Market encompasses pharmaceuticals aimed at reducing lipid levels in the bloodstream, crucial for managing cardiovascular risk. These drugs include statins, fibrates, niacin, and PCSK9 inhibitors, targeting conditions like hypercholesterolemia and hypertriglyceridemia. Market growth is propelled by rising cardiovascular disease prevalence, increasing geriatric population, and advancements in drug formulations. Emphasis on personalized medicine and combination therapies further enriches the market landscape, promoting effective lipid management and patient adherence.

The Antihyperlipidemic Drugs Market is experiencing robust growth due to rising cholesterol-related health concerns and increasing healthcare awareness. Statins dominate the market, being the top-performing sub-segment, given their proven efficacy in lowering LDL cholesterol levels. Following closely are PCSK9 inhibitors, which are gaining traction due to their effectiveness in patients resistant to traditional therapies. The fibrates segment also shows promising growth, particularly for patients with elevated triglyceride levels. Among non-statin therapies, bile acid sequestrants and cholesterol absorption inhibitors are witnessing gradual adoption, reflecting their role in comprehensive lipid management strategies. The nutraceuticals sub-segment is emerging as a viable alternative, driven by consumer preference for natural and preventive healthcare solutions. Combination therapies are becoming increasingly popular, offering enhanced lipid control and patient compliance. The market is further bolstered by continuous R&D investments, leading to the development of innovative drug formulations and delivery mechanisms, ensuring sustained market momentum.

Market Segmentation
Type	Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, PCSK9 Inhibitors, Nicotinic Acid, Omega-3 Fatty Acid Derivatives
Product	Tablets, Capsules, Injectables, Powders
Application	Hypercholesterolemia, Hypertriglyceridemia, Mixed Dyslipidemia, Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease
End User	Hospitals, Clinics, Homecare Settings, Academic and Research Institutes
Technology	Biotechnology, Synthetic Chemistry, Nanotechnology
Form	Immediate Release, Extended Release
Process	Research and Development, Manufacturing, Distribution
Functionality	Lipid-Lowering, Anti-inflammatory, Cardioprotective
Solutions	Patient Monitoring, Medication Management

The Antihyperlipidemic Drugs Market is characterized by a diverse distribution of market share, with established pharmaceutical giants leading the way. Pricing strategies remain competitive, influenced by the introduction of generic alternatives and innovative formulations. New product launches continue to invigorate the market, as companies invest in research and development to meet the growing demand for effective lipid-lowering therapies. The market's dynamic nature is further underscored by strategic collaborations and mergers, aimed at expanding product portfolios and enhancing market presence. Competition benchmarking reveals a landscape dominated by a few key players, with emerging companies challenging the status quo. Regulatory influences play a pivotal role, as stringent guidelines and approval processes impact market entry and product lifecycle. The market is witnessing a shift towards personalized medicine, with an emphasis on tailored treatment regimens. This trend is supported by advancements in biotechnology and genomics, which are expected to drive future growth. The interplay of regulatory frameworks and technological innovation continues to shape the competitive dynamics of the market.

Geographical Overview:

The antihyperlipidemic drugs market is witnessing varied growth across different regions, each presenting unique opportunities. North America remains a dominant player, propelled by a high prevalence of hyperlipidemia and advanced healthcare infrastructure. The region's robust research and development activities further catalyze market expansion. Europe follows, with increased awareness and government initiatives promoting cardiovascular health. The emphasis on preventive healthcare in Europe enhances the demand for antihyperlipidemic drugs. In Asia Pacific, the market is burgeoning due to rising incidences of lifestyle-related diseases and expanding healthcare access. Countries like India and China are emerging as key markets, driven by large patient populations and improving healthcare systems. Latin America and the Middle East & Africa are gradually gaining traction. In these regions, increasing healthcare investments and growing awareness about cardiovascular diseases are fostering market growth. Brazil and South Africa are notable emerging markets, with efforts to enhance healthcare delivery and access to medications.

The Antihyperlipidemic Drugs Market is being significantly influenced by global tariffs, geopolitical risks, and evolving supply chain dynamics. In Japan and South Korea, reliance on imported pharmaceutical ingredients is prompting a strategic pivot towards enhancing domestic production capabilities amidst rising trade tensions. China's focus is on bolstering its pharmaceutical sector through innovation and self-reliance, while Taiwan remains a pivotal player in drug manufacturing, though vulnerable to geopolitical frictions. The parent market is experiencing robust growth driven by rising cardiovascular disease prevalence and increased healthcare spending. By 2035, the market is anticipated to expand through strategic collaborations and technology advancements. Middle East conflicts exacerbate supply chain disruptions and energy price volatility, indirectly affecting production costs and market stability.

Key Trends and Drivers:

The antihyperlipidemic drugs market is experiencing robust growth driven by an aging global population and rising prevalence of cardiovascular diseases. Key trends include the increasing adoption of combination therapies, which offer enhanced efficacy and patient compliance. The development of novel drug delivery systems is also gaining traction, aiming to improve bioavailability and reduce side effects. Additionally, the rise of personalized medicine is influencing treatment protocols, tailoring therapies to individual genetic profiles. The growing awareness of lifestyle-induced hyperlipidemia is driving demand for effective management solutions, with healthcare providers focusing on preventive care. Technological advancements in drug discovery and development are accelerating the introduction of innovative antihyperlipidemic agents. Moreover, the expanding healthcare infrastructure in emerging economies is creating new opportunities for market expansion. Companies investing in research and development to create cost-effective, potent drugs are poised to capture significant market share. The market is also benefiting from increased government initiatives aimed at reducing the burden of cardiovascular diseases globally.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Antihyperlipidemic Drugs Market Overview

• 1.1 Objectives of the Study
• 1.2 Antihyperlipidemic Drugs Market Definition and Scope of the Report
• 1.3 Report Limitations
• 1.4 Years & Currency Considered in the Study
• 1.5 Research Methodologies
  • 1.5.1 Secondary Research
  • 1.5.2 Primary Research
  • 1.5.3 Market Size Estimation: Top-Down Approach
  • 1.5.4 Market Size Estimation: Bottom-Up Approach
  • 1.5.5 Data Triangulation and Validation

2: Executive Summary

• 2.1 Summary
• 2.2 Key Opinion Leaders
• 2.3 Key Highlights of the Market, by Type
• 2.4 Key Highlights of the Market, by Product
• 2.5 Key Highlights of the Market, by Application
• 2.6 Key Highlights of the Market, by End User
• 2.7 Key Highlights of the Market, by Technology
• 2.8 Key Highlights of the Market, by Form
• 2.9 Key Highlights of the Market, by Process
• 2.10 Key Highlights of the Market, by Functionality
• 2.11 Key Highlights of the Market, by Solutions
• 2.12 Key Highlights of the Market, by North America
• 2.13 Key Highlights of the Market, by Europe
• 2.14 Key Highlights of the Market, by Asia-Pacific
• 2.15 Key Highlights of the Market, by Latin America
• 2.16 Key Highlights of the Market, by Middle East
• 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

• 3.1 Market Attractiveness Analysis, by Region
• 3.2 Market Attractiveness Analysis, by Type
• 3.3 Market Attractiveness Analysis, by Product
• 3.4 Market Attractiveness Analysis, by Application
• 3.5 Market Attractiveness Analysis, by End User
• 3.6 Market Attractiveness Analysis, by Technology
• 3.7 Market Attractiveness Analysis, by Form
• 3.8 Market Attractiveness Analysis, by Process
• 3.9 Market Attractiveness Analysis, by Functionality
• 3.10 Market Attractiveness Analysis, by Solutions
• 3.11 Market Attractiveness Analysis, by North America
• 3.12 Market Attractiveness Analysis, by Europe
• 3.13 Market Attractiveness Analysis, by Asia-Pacific
• 3.14 Market Attractiveness Analysis, by Latin America
• 3.15 Market Attractiveness Analysis, by Middle East
• 3.16 Market Attractiveness Analysis, by Africa

4: Antihyperlipidemic Drugs Market Outlook

• 4.1 Antihyperlipidemic Drugs Market Segmentation
• 4.2 Market Dynamics
  • 4.2.1 Market Drivers
  • 4.2.2 Market Trends
  • 4.2.3 Market Restraints
  • 4.2.4 Market Opportunities
• 4.3 Porters Five Forces Analysis
  • 4.3.1 Threat of New Entrants
  • 4.3.2 Threat of Substitutes
  • 4.3.3 Bargaining Power of Buyers
  • 4.3.4 Bargaining Power of Supplier
  • 4.3.5 Competitive Rivalry
• 4.4 PESTLE Analysis
• 4.5 Value Chain Analysis
• 4.6 4Ps Model
• 4.7 ANSOFF Matrix

5: Antihyperlipidemic Drugs Market Strategy

• 5.1 Parent Market Analysis
• 5.2 Supply-Demand Analysis
• 5.3 Consumer Buying Interest
• 5.4 Case Study Analysis
• 5.5 Pricing Analysis
• 5.6 Regulatory Landscape
• 5.7 Supply Chain Analysis
• 5.8 Competition Product Analysis
• 5.9 Recent Developments

6: Antihyperlipidemic Drugs Market Size

• 6.1 Antihyperlipidemic Drugs Market Size, by Value
• 6.2 Antihyperlipidemic Drugs Market Size, by Volume

7: Antihyperlipidemic Drugs Market, by Type

• 7.1 Market Overview
• 7.2 Statins
  • 7.2.1 Key Market Trends & Opportunity Analysis
  • 7.2.2 Market Size and Forecast, by Region
• 7.3 Bile Acid Sequestrants
  • 7.3.1 Key Market Trends & Opportunity Analysis
  • 7.3.2 Market Size and Forecast, by Region
• 7.4 Cholesterol Absorption Inhibitors
  • 7.4.1 Key Market Trends & Opportunity Analysis
  • 7.4.2 Market Size and Forecast, by Region
• 7.5 Fibric Acid Derivatives
  • 7.5.1 Key Market Trends & Opportunity Analysis
  • 7.5.2 Market Size and Forecast, by Region
• 7.6 PCSK9 Inhibitors
  • 7.6.1 Key Market Trends & Opportunity Analysis
  • 7.6.2 Market Size and Forecast, by Region
• 7.7 Nicotinic Acid
  • 7.7.1 Key Market Trends & Opportunity Analysis
  • 7.7.2 Market Size and Forecast, by Region
• 7.8 Omega-3 Fatty Acid Derivatives
  • 7.8.1 Key Market Trends & Opportunity Analysis
  • 7.8.2 Market Size and Forecast, by Region
• 7.9 Others
  • 7.9.1 Key Market Trends & Opportunity Analysis
  • 7.9.2 Market Size and Forecast, by Region

8: Antihyperlipidemic Drugs Market, by Product

• 8.1 Market Overview
• 8.2 Tablets
  • 8.2.1 Key Market Trends & Opportunity Analysis
  • 8.2.2 Market Size and Forecast, by Region
• 8.3 Capsules
  • 8.3.1 Key Market Trends & Opportunity Analysis
  • 8.3.2 Market Size and Forecast, by Region
• 8.4 Injectables
  • 8.4.1 Key Market Trends & Opportunity Analysis
  • 8.4.2 Market Size and Forecast, by Region
• 8.5 Powders
  • 8.5.1 Key Market Trends & Opportunity Analysis
  • 8.5.2 Market Size and Forecast, by Region
• 8.6 Others
  • 8.6.1 Key Market Trends & Opportunity Analysis
  • 8.6.2 Market Size and Forecast, by Region

9: Antihyperlipidemic Drugs Market, by Application

• 9.1 Market Overview
• 9.2 Hypercholesterolemia
  • 9.2.1 Key Market Trends & Opportunity Analysis
  • 9.2.2 Market Size and Forecast, by Region
• 9.3 Hypertriglyceridemia
  • 9.3.1 Key Market Trends & Opportunity Analysis
  • 9.3.2 Market Size and Forecast, by Region
• 9.4 Mixed Dyslipidemia
  • 9.4.1 Key Market Trends & Opportunity Analysis
  • 9.4.2 Market Size and Forecast, by Region
• 9.5 Familial Hypercholesterolemia
  • 9.5.1 Key Market Trends & Opportunity Analysis
  • 9.5.2 Market Size and Forecast, by Region
• 9.6 Atherosclerotic Cardiovascular Disease
  • 9.6.1 Key Market Trends & Opportunity Analysis
  • 9.6.2 Market Size and Forecast, by Region
• 9.7 Others
  • 9.7.1 Key Market Trends & Opportunity Analysis
  • 9.7.2 Market Size and Forecast, by Region

10: Antihyperlipidemic Drugs Market, by End User

• 10.1 Market Overview
• 10.2 Hospitals
  • 10.2.1 Key Market Trends & Opportunity Analysis
  • 10.2.2 Market Size and Forecast, by Region
• 10.3 Clinics
  • 10.3.1 Key Market Trends & Opportunity Analysis
  • 10.3.2 Market Size and Forecast, by Region
• 10.4 Homecare Settings
  • 10.4.1 Key Market Trends & Opportunity Analysis
  • 10.4.2 Market Size and Forecast, by Region
• 10.5 Academic and Research Institutes
  • 10.5.1 Key Market Trends & Opportunity Analysis
  • 10.5.2 Market Size and Forecast, by Region
• 10.6 Others
  • 10.6.1 Key Market Trends & Opportunity Analysis
  • 10.6.2 Market Size and Forecast, by Region

11: Antihyperlipidemic Drugs Market, by Technology

• 11.1 Market Overview
• 11.2 Biotechnology
  • 11.2.1 Key Market Trends & Opportunity Analysis
  • 11.2.2 Market Size and Forecast, by Region
• 11.3 Synthetic Chemistry
  • 11.3.1 Key Market Trends & Opportunity Analysis
  • 11.3.2 Market Size and Forecast, by Region
• 11.4 Nanotechnology
  • 11.4.1 Key Market Trends & Opportunity Analysis
  • 11.4.2 Market Size and Forecast, by Region
• 11.5 Others
  • 11.5.1 Key Market Trends & Opportunity Analysis
  • 11.5.2 Market Size and Forecast, by Region

12: Antihyperlipidemic Drugs Market, by Form

• 12.1 Market Overview
• 12.2 Immediate Release
  • 12.2.1 Key Market Trends & Opportunity Analysis
  • 12.2.2 Market Size and Forecast, by Region
• 12.3 Extended Release
  • 12.3.1 Key Market Trends & Opportunity Analysis
  • 12.3.2 Market Size and Forecast, by Region
• 12.4 Others
  • 12.4.1 Key Market Trends & Opportunity Analysis
  • 12.4.2 Market Size and Forecast, by Region

13: Antihyperlipidemic Drugs Market, by Process

• 13.1 Market Overview
• 13.2 Research and Development
  • 13.2.1 Key Market Trends & Opportunity Analysis
  • 13.2.2 Market Size and Forecast, by Region
• 13.3 Manufacturing
  • 13.3.1 Key Market Trends & Opportunity Analysis
  • 13.3.2 Market Size and Forecast, by Region
• 13.4 Distribution
  • 13.4.1 Key Market Trends & Opportunity Analysis
  • 13.4.2 Market Size and Forecast, by Region
• 13.5 Others
  • 13.5.1 Key Market Trends & Opportunity Analysis
  • 13.5.2 Market Size and Forecast, by Region

14: Antihyperlipidemic Drugs Market, by Functionality

• 14.1 Market Overview
• 14.2 Lipid-Lowering
  • 14.2.1 Key Market Trends & Opportunity Analysis
  • 14.2.2 Market Size and Forecast, by Region
• 14.3 Anti-inflammatory
  • 14.3.1 Key Market Trends & Opportunity Analysis
  • 14.3.2 Market Size and Forecast, by Region
• 14.4 Cardioprotective
  • 14.4.1 Key Market Trends & Opportunity Analysis
  • 14.4.2 Market Size and Forecast, by Region
• 14.5 Others
  • 14.5.1 Key Market Trends & Opportunity Analysis
  • 14.5.2 Market Size and Forecast, by Region

15: Antihyperlipidemic Drugs Market, by Solutions

• 15.1 Market Overview
• 15.2 Patient Monitoring
  • 15.2.1 Key Market Trends & Opportunity Analysis
  • 15.2.2 Market Size and Forecast, by Region
• 15.3 Medication Management
  • 15.3.1 Key Market Trends & Opportunity Analysis
  • 15.3.2 Market Size and Forecast, by Region
• 15.4 Others
  • 15.4.1 Key Market Trends & Opportunity Analysis
  • 15.4.2 Market Size and Forecast, by Region

16: Antihyperlipidemic Drugs Market, by Region

• 16.1 Overview
• 16.2 North America
  • 16.2.1 Key Market Trends and Opportunities
  • 16.2.2 North America Market Size and Forecast, by Type
  • 16.2.3 North America Market Size and Forecast, by Product
  • 16.2.4 North America Market Size and Forecast, by Application
  • 16.2.5 North America Market Size and Forecast, by End User
  • 16.2.6 North America Market Size and Forecast, by Technology
  • 16.2.7 North America Market Size and Forecast, by Form
  • 16.2.8 North America Market Size and Forecast, by Process
  • 16.2.9 North America Market Size and Forecast, by Functionality
  • 16.2.10 North America Market Size and Forecast, by Solutions
  • 16.2.11 North America Market Size and Forecast, by Country
  • 16.2.12 United States
    • 16.2.9.1 United States Market Size and Forecast, by Type
    • 16.2.9.2 United States Market Size and Forecast, by Product
    • 16.2.9.3 United States Market Size and Forecast, by Application
    • 16.2.9.4 United States Market Size and Forecast, by End User
    • 16.2.9.5 United States Market Size and Forecast, by Technology
    • 16.2.9.6 United States Market Size and Forecast, by Form
    • 16.2.9.7 United States Market Size and Forecast, by Process
    • 16.2.9.8 United States Market Size and Forecast, by Functionality
    • 16.2.9.9 United States Market Size and Forecast, by Solutions
    • 16.2.9.10 Local Competition Analysis
    • 16.2.9.11 Local Market Analysis
  • 16.2.1 Canada
    • 16.2.10.1 Canada Market Size and Forecast, by Type
    • 16.2.10.2 Canada Market Size and Forecast, by Product
    • 16.2.10.3 Canada Market Size and Forecast, by Application
    • 16.2.10.4 Canada Market Size and Forecast, by End User
    • 16.2.10.5 Canada Market Size and Forecast, by Technology
    • 16.2.10.6 Canada Market Size and Forecast, by Form
    • 16.2.10.7 Canada Market Size and Forecast, by Process
    • 16.2.10.8 Canada Market Size and Forecast, by Functionality
    • 16.2.10.9 Canada Market Size and Forecast, by Solutions
    • 16.2.10.10 Local Competition Analysis
    • 16.2.10.11 Local Market Analysis
• 16.1 Europe
  • 16.3.1 Key Market Trends and Opportunities
  • 16.3.2 Europe Market Size and Forecast, by Type
  • 16.3.3 Europe Market Size and Forecast, by Product
  • 16.3.4 Europe Market Size and Forecast, by Application
  • 16.3.5 Europe Market Size and Forecast, by End User
  • 16.3.6 Europe Market Size and Forecast, by Technology
  • 16.3.7 Europe Market Size and Forecast, by Form
  • 16.3.8 Europe Market Size and Forecast, by Process
  • 16.3.9 Europe Market Size and Forecast, by Functionality
  • 16.3.10 Europe Market Size and Forecast, by Solutions
  • 16.3.11 Europe Market Size and Forecast, by Country
  • 16.3.12 United Kingdom
    • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
    • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
    • 16.3.9.3 United Kingdom Market Size and Forecast, by Application
    • 16.3.9.4 United Kingdom Market Size and Forecast, by End User
    • 16.3.9.5 United Kingdom Market Size and Forecast, by Technology
    • 16.3.9.6 United Kingdom Market Size and Forecast, by Form
    • 16.3.9.7 United Kingdom Market Size and Forecast, by Process
    • 16.3.9.8 United Kingdom Market Size and Forecast, by Functionality
    • 16.3.9.9 United Kingdom Market Size and Forecast, by Solutions
    • 16.3.9.10 Local Competition Analysis
    • 16.3.9.11 Local Market Analysis
  • 16.3.1 Germany
    • 16.3.10.1 Germany Market Size and Forecast, by Type
    • 16.3.10.2 Germany Market Size and Forecast, by Product
    • 16.3.10.3 Germany Market Size and Forecast, by Application
    • 16.3.10.4 Germany Market Size and Forecast, by End User
    • 16.3.10.5 Germany Market Size and Forecast, by Technology
    • 16.3.10.6 Germany Market Size and Forecast, by Form
    • 16.3.10.7 Germany Market Size and Forecast, by Process
    • 16.3.10.8 Germany Market Size and Forecast, by Functionality
    • 16.3.10.9 Germany Market Size and Forecast, by Solutions
    • 16.3.10.10 Local Competition Analysis
    • 16.3.10.11 Local Market Analysis
  • 16.3.1 France
    • 16.3.11.1 France Market Size and Forecast, by Type
    • 16.3.11.2 France Market Size and Forecast, by Product
    • 16.3.11.3 France Market Size and Forecast, by Application
    • 16.3.11.4 France Market Size and Forecast, by End User
    • 16.3.11.5 France Market Size and Forecast, by Technology
    • 16.3.11.6 France Market Size and Forecast, by Form
    • 16.3.11.7 France Market Size and Forecast, by Process
    • 16.3.11.8 France Market Size and Forecast, by Functionality
    • 16.3.11.9 France Market Size and Forecast, by Solutions
    • 16.3.11.10 Local Competition Analysis
    • 16.3.11.11 Local Market Analysis
  • 16.3.1 Spain
    • 16.3.12.1 Spain Market Size and Forecast, by Type
    • 16.3.12.2 Spain Market Size and Forecast, by Product
    • 16.3.12.3 Spain Market Size and Forecast, by Application
    • 16.3.12.4 Spain Market Size and Forecast, by End User
    • 16.3.12.5 Spain Market Size and Forecast, by Technology
    • 16.3.12.6 Spain Market Size and Forecast, by Form
    • 16.3.12.7 Spain Market Size and Forecast, by Process
    • 16.3.12.8 Spain Market Size and Forecast, by Functionality
    • 16.3.12.9 Spain Market Size and Forecast, by Solutions
    • 16.3.12.10 Local Competition Analysis
    • 16.3.12.11 Local Market Analysis
  • 16.3.1 Italy
    • 16.3.13.1 Italy Market Size and Forecast, by Type
    • 16.3.13.2 Italy Market Size and Forecast, by Product
    • 16.3.13.3 Italy Market Size and Forecast, by Application
    • 16.3.13.4 Italy Market Size and Forecast, by End User
    • 16.3.13.5 Italy Market Size and Forecast, by Technology
    • 16.3.13.6 Italy Market Size and Forecast, by Form
    • 16.3.13.7 Italy Market Size and Forecast, by Process
    • 16.3.13.8 Italy Market Size and Forecast, by Functionality
    • 16.3.13.9 Italy Market Size and Forecast, by Solutions
    • 16.3.13.10 Local Competition Analysis
    • 16.3.13.11 Local Market Analysis
  • 16.3.1 Netherlands
    • 16.3.14.1 Netherlands Market Size and Forecast, by Type
    • 16.3.14.2 Netherlands Market Size and Forecast, by Product
    • 16.3.14.3 Netherlands Market Size and Forecast, by Application
    • 16.3.14.4 Netherlands Market Size and Forecast, by End User
    • 16.3.14.5 Netherlands Market Size and Forecast, by Technology
    • 16.3.14.6 Netherlands Market Size and Forecast, by Form
    • 16.3.14.7 Netherlands Market Size and Forecast, by Process
    • 16.3.14.8 Netherlands Market Size and Forecast, by Functionality
    • 16.3.14.9 Netherlands Market Size and Forecast, by Solutions
    • 16.3.14.10 Local Competition Analysis
    • 16.3.14.11 Local Market Analysis
  • 16.3.1 Sweden
    • 16.3.15.1 Sweden Market Size and Forecast, by Type
    • 16.3.15.2 Sweden Market Size and Forecast, by Product
    • 16.3.15.3 Sweden Market Size and Forecast, by Application
    • 16.3.15.4 Sweden Market Size and Forecast, by End User
    • 16.3.15.5 Sweden Market Size and Forecast, by Technology
    • 16.3.15.6 Sweden Market Size and Forecast, by Form
    • 16.3.15.7 Sweden Market Size and Forecast, by Process
    • 16.3.15.8 Sweden Market Size and Forecast, by Functionality
    • 16.3.15.9 Sweden Market Size and Forecast, by Solutions
    • 16.3.15.10 Local Competition Analysis
    • 16.3.15.11 Local Market Analysis
  • 16.3.1 Switzerland
    • 16.3.16.1 Switzerland Market Size and Forecast, by Type
    • 16.3.16.2 Switzerland Market Size and Forecast, by Product
    • 16.3.16.3 Switzerland Market Size and Forecast, by Application
    • 16.3.16.4 Switzerland Market Size and Forecast, by End User
    • 16.3.16.5 Switzerland Market Size and Forecast, by Technology
    • 16.3.16.6 Switzerland Market Size and Forecast, by Form
    • 16.3.16.7 Switzerland Market Size and Forecast, by Process
    • 16.3.16.8 Switzerland Market Size and Forecast, by Functionality
    • 16.3.16.9 Switzerland Market Size and Forecast, by Solutions
    • 16.3.16.10 Local Competition Analysis
    • 16.3.16.11 Local Market Analysis
  • 16.3.1 Denmark
    • 16.3.17.1 Denmark Market Size and Forecast, by Type
    • 16.3.17.2 Denmark Market Size and Forecast, by Product
    • 16.3.17.3 Denmark Market Size and Forecast, by Application
    • 16.3.17.4 Denmark Market Size and Forecast, by End User
    • 16.3.17.5 Denmark Market Size and Forecast, by Technology
    • 16.3.17.6 Denmark Market Size and Forecast, by Form
    • 16.3.17.7 Denmark Market Size and Forecast, by Process
    • 16.3.17.8 Denmark Market Size and Forecast, by Functionality
    • 16.3.17.9 Denmark Market Size and Forecast, by Solutions
    • 16.3.17.10 Local Competition Analysis
    • 16.3.17.11 Local Market Analysis
  • 16.3.1 Finland
    • 16.3.18.1 Finland Market Size and Forecast, by Type
    • 16.3.18.2 Finland Market Size and Forecast, by Product
    • 16.3.18.3 Finland Market Size and Forecast, by Application
    • 16.3.18.4 Finland Market Size and Forecast, by End User
    • 16.3.18.5 Finland Market Size and Forecast, by Technology
    • 16.3.18.6 Finland Market Size and Forecast, by Form
    • 16.3.18.7 Finland Market Size and Forecast, by Process
    • 16.3.18.8 Finland Market Size and Forecast, by Functionality
    • 16.3.18.9 Finland Market Size and Forecast, by Solutions
    • 16.3.18.10 Local Competition Analysis
    • 16.3.18.11 Local Market Analysis
  • 16.3.1 Russia
    • 16.3.19.1 Russia Market Size and Forecast, by Type
    • 16.3.19.2 Russia Market Size and Forecast, by Product
    • 16.3.19.3 Russia Market Size and Forecast, by Application
    • 16.3.19.4 Russia Market Size and Forecast, by End User
    • 16.3.19.5 Russia Market Size and Forecast, by Technology
    • 16.3.19.6 Russia Market Size and Forecast, by Form
    • 16.3.19.7 Russia Market Size and Forecast, by Process
    • 16.3.19.8 Russia Market Size and Forecast, by Functionality
    • 16.3.19.9 Russia Market Size and Forecast, by Solutions
    • 16.3.19.10 Local Competition Analysis
    • 16.3.19.11 Local Market Analysis
  • 16.3.1 Rest of Europe
    • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
    • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
    • 16.3.20.3 Rest of Europe Market Size and Forecast, by Application
    • 16.3.20.4 Rest of Europe Market Size and Forecast, by End User
    • 16.3.20.5 Rest of Europe Market Size and Forecast, by Technology
    • 16.3.20.6 Rest of Europe Market Size and Forecast, by Form
    • 16.3.20.7 Rest of Europe Market Size and Forecast, by Process
    • 16.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
    • 16.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
    • 16.3.20.10 Local Competition Analysis
    • 16.3.20.11 Local Market Analysis
• 16.1 Asia-Pacific
  • 16.4.1 Key Market Trends and Opportunities
  • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
  • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
  • 16.4.4 Asia-Pacific Market Size and Forecast, by Application
  • 16.4.5 Asia-Pacific Market Size and Forecast, by End User
  • 16.4.6 Asia-Pacific Market Size and Forecast, by Technology
  • 16.4.7 Asia-Pacific Market Size and Forecast, by Form
  • 16.4.8 Asia-Pacific Market Size and Forecast, by Process
  • 16.4.9 Asia-Pacific Market Size and Forecast, by Functionality
  • 16.4.10 Asia-Pacific Market Size and Forecast, by Solutions
  • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
  • 16.4.12 China
    • 16.4.9.1 China Market Size and Forecast, by Type
    • 16.4.9.2 China Market Size and Forecast, by Product
    • 16.4.9.3 China Market Size and Forecast, by Application
    • 16.4.9.4 China Market Size and Forecast, by End User
    • 16.4.9.5 China Market Size and Forecast, by Technology
    • 16.4.9.6 China Market Size and Forecast, by Form
    • 16.4.9.7 China Market Size and Forecast, by Process
    • 16.4.9.8 China Market Size and Forecast, by Functionality
    • 16.4.9.9 China Market Size and Forecast, by Solutions
    • 16.4.9.10 Local Competition Analysis
    • 16.4.9.11 Local Market Analysis
  • 16.4.1 India
    • 16.4.10.1 India Market Size and Forecast, by Type
    • 16.4.10.2 India Market Size and Forecast, by Product
    • 16.4.10.3 India Market Size and Forecast, by Application
    • 16.4.10.4 India Market Size and Forecast, by End User
    • 16.4.10.5 India Market Size and Forecast, by Technology
    • 16.4.10.6 India Market Size and Forecast, by Form
    • 16.4.10.7 India Market Size and Forecast, by Process
    • 16.4.10.8 India Market Size and Forecast, by Functionality
    • 16.4.10.9 India Market Size and Forecast, by Solutions
    • 16.4.10.10 Local Competition Analysis
    • 16.4.10.11 Local Market Analysis
  • 16.4.1 Japan
    • 16.4.11.1 Japan Market Size and Forecast, by Type
    • 16.4.11.2 Japan Market Size and Forecast, by Product
    • 16.4.11.3 Japan Market Size and Forecast, by Application
    • 16.4.11.4 Japan Market Size and Forecast, by End User
    • 16.4.11.5 Japan Market Size and Forecast, by Technology
    • 16.4.11.6 Japan Market Size and Forecast, by Form
    • 16.4.11.7 Japan Market Size and Forecast, by Process
    • 16.4.11.8 Japan Market Size and Forecast, by Functionality
    • 16.4.11.9 Japan Market Size and Forecast, by Solutions
    • 16.4.11.10 Local Competition Analysis
    • 16.4.11.11 Local Market Analysis
  • 16.4.1 South Korea
    • 16.4.12.1 South Korea Market Size and Forecast, by Type
    • 16.4.12.2 South Korea Market Size and Forecast, by Product
    • 16.4.12.3 South Korea Market Size and Forecast, by Application
    • 16.4.12.4 South Korea Market Size and Forecast, by End User
    • 16.4.12.5 South Korea Market Size and Forecast, by Technology
    • 16.4.12.6 South Korea Market Size and Forecast, by Form
    • 16.4.12.7 South Korea Market Size and Forecast, by Process
    • 16.4.12.8 South Korea Market Size and Forecast, by Functionality
    • 16.4.12.9 South Korea Market Size and Forecast, by Solutions
    • 16.4.12.10 Local Competition Analysis
    • 16.4.12.11 Local Market Analysis
  • 16.4.1 Australia
    • 16.4.13.1 Australia Market Size and Forecast, by Type
    • 16.4.13.2 Australia Market Size and Forecast, by Product
    • 16.4.13.3 Australia Market Size and Forecast, by Application
    • 16.4.13.4 Australia Market Size and Forecast, by End User
    • 16.4.13.5 Australia Market Size and Forecast, by Technology
    • 16.4.13.6 Australia Market Size and Forecast, by Form
    • 16.4.13.7 Australia Market Size and Forecast, by Process
    • 16.4.13.8 Australia Market Size and Forecast, by Functionality
    • 16.4.13.9 Australia Market Size and Forecast, by Solutions
    • 16.4.13.10 Local Competition Analysis
    • 16.4.13.11 Local Market Analysis
  • 16.4.1 Singapore
    • 16.4.14.1 Singapore Market Size and Forecast, by Type
    • 16.4.14.2 Singapore Market Size and Forecast, by Product
    • 16.4.14.3 Singapore Market Size and Forecast, by Application
    • 16.4.14.4 Singapore Market Size and Forecast, by End User
    • 16.4.14.5 Singapore Market Size and Forecast, by Technology
    • 16.4.14.6 Singapore Market Size and Forecast, by Form
    • 16.4.14.7 Singapore Market Size and Forecast, by Process
    • 16.4.14.8 Singapore Market Size and Forecast, by Functionality
    • 16.4.14.9 Singapore Market Size and Forecast, by Solutions
    • 16.4.14.10 Local Competition Analysis
    • 16.4.14.11 Local Market Analysis
  • 16.4.1 Indonesia
    • 16.4.15.1 Indonesia Market Size and Forecast, by Type
    • 16.4.15.2 Indonesia Market Size and Forecast, by Product
    • 16.4.15.3 Indonesia Market Size and Forecast, by Application
    • 16.4.15.4 Indonesia Market Size and Forecast, by End User
    • 16.4.15.5 Indonesia Market Size and Forecast, by Technology
    • 16.4.15.6 Indonesia Market Size and Forecast, by Form
    • 16.4.15.7 Indonesia Market Size and Forecast, by Process
    • 16.4.15.8 Indonesia Market Size and Forecast, by Functionality
    • 16.4.15.9 Indonesia Market Size and Forecast, by Solutions
    • 16.4.15.10 Local Competition Analysis
    • 16.4.15.11 Local Market Analysis
  • 16.4.1 Taiwan
    • 16.4.16.1 Taiwan Market Size and Forecast, by Type
    • 16.4.16.2 Taiwan Market Size and Forecast, by Product
    • 16.4.16.3 Taiwan Market Size and Forecast, by Application
    • 16.4.16.4 Taiwan Market Size and Forecast, by End User
    • 16.4.16.5 Taiwan Market Size and Forecast, by Technology
    • 16.4.16.6 Taiwan Market Size and Forecast, by Form
    • 16.4.16.7 Taiwan Market Size and Forecast, by Process
    • 16.4.16.8 Taiwan Market Size and Forecast, by Functionality
    • 16.4.16.9 Taiwan Market Size and Forecast, by Solutions
    • 16.4.16.10 Local Competition Analysis
    • 16.4.16.11 Local Market Analysis
  • 16.4.1 Malaysia
    • 16.4.17.1 Malaysia Market Size and Forecast, by Type
    • 16.4.17.2 Malaysia Market Size and Forecast, by Product
    • 16.4.17.3 Malaysia Market Size and Forecast, by Application
    • 16.4.17.4 Malaysia Market Size and Forecast, by End User
    • 16.4.17.5 Malaysia Market Size and Forecast, by Technology
    • 16.4.17.6 Malaysia Market Size and Forecast, by Form
    • 16.4.17.7 Malaysia Market Size and Forecast, by Process
    • 16.4.17.8 Malaysia Market Size and Forecast, by Functionality
    • 16.4.17.9 Malaysia Market Size and Forecast, by Solutions
    • 16.4.17.10 Local Competition Analysis
    • 16.4.17.11 Local Market Analysis
  • 16.4.1 Rest of Asia-Pacific
    • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
    • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
    • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
    • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by End User
    • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Form
    • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
    • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
    • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.18.10 Local Competition Analysis
    • 16.4.18.11 Local Market Analysis
• 16.1 Latin America
  • 16.5.1 Key Market Trends and Opportunities
  • 16.5.2 Latin America Market Size and Forecast, by Type
  • 16.5.3 Latin America Market Size and Forecast, by Product
  • 16.5.4 Latin America Market Size and Forecast, by Application
  • 16.5.5 Latin America Market Size and Forecast, by End User
  • 16.5.6 Latin America Market Size and Forecast, by Technology
  • 16.5.7 Latin America Market Size and Forecast, by Form
  • 16.5.8 Latin America Market Size and Forecast, by Process
  • 16.5.9 Latin America Market Size and Forecast, by Functionality
  • 16.5.10 Latin America Market Size and Forecast, by Solutions
  • 16.5.11 Latin America Market Size and Forecast, by Country
  • 16.5.12 Brazil
    • 16.5.9.1 Brazil Market Size and Forecast, by Type
    • 16.5.9.2 Brazil Market Size and Forecast, by Product
    • 16.5.9.3 Brazil Market Size and Forecast, by Application
    • 16.5.9.4 Brazil Market Size and Forecast, by End User
    • 16.5.9.5 Brazil Market Size and Forecast, by Technology
    • 16.5.9.6 Brazil Market Size and Forecast, by Form
    • 16.5.9.7 Brazil Market Size and Forecast, by Process
    • 16.5.9.8 Brazil Market Size and Forecast, by Functionality
    • 16.5.9.9 Brazil Market Size and Forecast, by Solutions
    • 16.5.9.10 Local Competition Analysis
    • 16.5.9.11 Local Market Analysis
  • 16.5.1 Mexico
    • 16.5.10.1 Mexico Market Size and Forecast, by Type
    • 16.5.10.2 Mexico Market Size and Forecast, by Product
    • 16.5.10.3 Mexico Market Size and Forecast, by Application
    • 16.5.10.4 Mexico Market Size and Forecast, by End User
    • 16.5.10.5 Mexico Market Size and Forecast, by Technology
    • 16.5.10.6 Mexico Market Size and Forecast, by Form
    • 16.5.10.7 Mexico Market Size and Forecast, by Process
    • 16.5.10.8 Mexico Market Size and Forecast, by Functionality
    • 16.5.10.9 Mexico Market Size and Forecast, by Solutions
    • 16.5.10.10 Local Competition Analysis
    • 16.5.10.11 Local Market Analysis
  • 16.5.1 Argentina
    • 16.5.11.1 Argentina Market Size and Forecast, by Type
    • 16.5.11.2 Argentina Market Size and Forecast, by Product
    • 16.5.11.3 Argentina Market Size and Forecast, by Application
    • 16.5.11.4 Argentina Market Size and Forecast, by End User
    • 16.5.11.5 Argentina Market Size and Forecast, by Technology
    • 16.5.11.6 Argentina Market Size and Forecast, by Form
    • 16.5.11.7 Argentina Market Size and Forecast, by Process
    • 16.5.11.8 Argentina Market Size and Forecast, by Functionality
    • 16.5.11.9 Argentina Market Size and Forecast, by Solutions
    • 16.5.11.10 Local Competition Analysis
    • 16.5.11.11 Local Market Analysis
  • 16.5.1 Rest of Latin America
    • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
    • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
    • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Application
    • 16.5.12.4 Rest of Latin America Market Size and Forecast, by End User
    • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Technology
    • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Form
    • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Process
    • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
    • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
    • 16.5.12.10 Local Competition Analysis
    • 16.5.12.11 Local Market Analysis
• 16.1 Middle East and Africa
  • 16.6.1 Key Market Trends and Opportunities
  • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
  • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
  • 16.6.4 Middle East and Africa Market Size and Forecast, by Application
  • 16.6.5 Middle East and Africa Market Size and Forecast, by End User
  • 16.6.6 Middle East and Africa Market Size and Forecast, by Technology
  • 16.6.7 Middle East and Africa Market Size and Forecast, by Form
  • 16.6.8 Middle East and Africa Market Size and Forecast, by Process
  • 16.6.9 Middle East and Africa Market Size and Forecast, by Functionality
  • 16.6.10 Middle East and Africa Market Size and Forecast, by Solutions
  • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
  • 16.6.12 Saudi Arabia
    • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
    • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
    • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Application
    • 16.6.9.4 Saudi Arabia Market Size and Forecast, by End User
    • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Technology
    • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Form
    • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Process
    • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
    • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
    • 16.6.9.10 Local Competition Analysis
    • 16.6.9.11 Local Market Analysis
  • 16.6.1 UAE
    • 16.6.10.1 UAE Market Size and Forecast, by Type
    • 16.6.10.2 UAE Market Size and Forecast, by Product
    • 16.6.10.3 UAE Market Size and Forecast, by Application
    • 16.6.10.4 UAE Market Size and Forecast, by End User
    • 16.6.10.5 UAE Market Size and Forecast, by Technology
    • 16.6.10.6 UAE Market Size and Forecast, by Form
    • 16.6.10.7 UAE Market Size and Forecast, by Process
    • 16.6.10.8 UAE Market Size and Forecast, by Functionality
    • 16.6.10.9 UAE Market Size and Forecast, by Solutions
    • 16.6.10.10 Local Competition Analysis
    • 16.6.10.11 Local Market Analysis
  • 16.6.1 South Africa
    • 16.6.11.1 South Africa Market Size and Forecast, by Type
    • 16.6.11.2 South Africa Market Size and Forecast, by Product
    • 16.6.11.3 South Africa Market Size and Forecast, by Application
    • 16.6.11.4 South Africa Market Size and Forecast, by End User
    • 16.6.11.5 South Africa Market Size and Forecast, by Technology
    • 16.6.11.6 South Africa Market Size and Forecast, by Form
    • 16.6.11.7 South Africa Market Size and Forecast, by Process
    • 16.6.11.8 South Africa Market Size and Forecast, by Functionality
    • 16.6.11.9 South Africa Market Size and Forecast, by Solutions
    • 16.6.11.10 Local Competition Analysis
    • 16.6.11.11 Local Market Analysis
  • 16.6.1 Rest of MEA
    • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
    • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
    • 16.6.12.3 Rest of MEA Market Size and Forecast, by Application
    • 16.6.12.4 Rest of MEA Market Size and Forecast, by End User
    • 16.6.12.5 Rest of MEA Market Size and Forecast, by Technology
    • 16.6.12.6 Rest of MEA Market Size and Forecast, by Form
    • 16.6.12.7 Rest of MEA Market Size and Forecast, by Process
    • 16.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
    • 16.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
    • 16.6.12.10 Local Competition Analysis
    • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

• 17.1 Overview
• 17.2 Market Share Analysis
• 17.3 Key Player Positioning
• 17.4 Competitive Leadership Mapping
  • 17.4.1 Star Players
  • 17.4.2 Innovators
  • 17.4.3 Emerging Players
• 17.5 Vendor Benchmarking
• 17.6 Developmental Strategy Benchmarking
  • 17.6.1 New Product Developments
  • 17.6.2 Product Launches
  • 17.6.3 Business Expansions
  • 17.6.4 Partnerships, Joint Ventures, and Collaborations
  • 17.6.5 Mergers and Acquisitions

18: Company Profiles

• 18.1 Amarin
  • 18.1.1 Company Overview
  • 18.1.2 Company Snapshot
  • 18.1.3 Business Segments
  • 18.1.4 Business Performance
  • 18.1.5 Product Offerings
  • 18.1.6 Key Developmental Strategies
  • 18.1.7 SWOT Analysis
• 18.2 Esperion Therapeutics
  • 18.2.1 Company Overview
  • 18.2.2 Company Snapshot
  • 18.2.3 Business Segments
  • 18.2.4 Business Performance
  • 18.2.5 Product Offerings
  • 18.2.6 Key Developmental Strategies
  • 18.2.7 SWOT Analysis
• 18.3 Chiesi Farmaceutici
  • 18.3.1 Company Overview
  • 18.3.2 Company Snapshot
  • 18.3.3 Business Segments
  • 18.3.4 Business Performance
  • 18.3.5 Product Offerings
  • 18.3.6 Key Developmental Strategies
  • 18.3.7 SWOT Analysis
• 18.4 Nippon Chemiphar
  • 18.4.1 Company Overview
  • 18.4.2 Company Snapshot
  • 18.4.3 Business Segments
  • 18.4.4 Business Performance
  • 18.4.5 Product Offerings
  • 18.4.6 Key Developmental Strategies
  • 18.4.7 SWOT Analysis
• 18.5 Kowa Pharmaceuticals
  • 18.5.1 Company Overview
  • 18.5.2 Company Snapshot
  • 18.5.3 Business Segments
  • 18.5.4 Business Performance
  • 18.5.5 Product Offerings
  • 18.5.6 Key Developmental Strategies
  • 18.5.7 SWOT Analysis
• 18.6 Recordati
  • 18.6.1 Company Overview
  • 18.6.2 Company Snapshot
  • 18.6.3 Business Segments
  • 18.6.4 Business Performance
  • 18.6.5 Product Offerings
  • 18.6.6 Key Developmental Strategies
  • 18.6.7 SWOT Analysis
• 18.7 Daiichi Sankyo
  • 18.7.1 Company Overview
  • 18.7.2 Company Snapshot
  • 18.7.3 Business Segments
  • 18.7.4 Business Performance
  • 18.7.5 Product Offerings
  • 18.7.6 Key Developmental Strategies
  • 18.7.7 SWOT Analysis
• 18.8 Zydus Cadila
  • 18.8.1 Company Overview
  • 18.8.2 Company Snapshot
  • 18.8.3 Business Segments
  • 18.8.4 Business Performance
  • 18.8.5 Product Offerings
  • 18.8.6 Key Developmental Strategies
  • 18.8.7 SWOT Analysis
• 18.9 Torrent Pharmaceuticals
  • 18.9.1 Company Overview
  • 18.9.2 Company Snapshot
  • 18.9.3 Business Segments
  • 18.9.4 Business Performance
  • 18.9.5 Product Offerings
  • 18.9.6 Key Developmental Strategies
  • 18.9.7 SWOT Analysis
• 18.10 Lupin Pharmaceuticals
  • 18.10.1 Company Overview
  • 18.10.2 Company Snapshot
  • 18.10.3 Business Segments
  • 18.10.4 Business Performance
  • 18.10.5 Product Offerings
  • 18.10.6 Key Developmental Strategies
  • 18.10.7 SWOT Analysis
• 18.11 Dr. Reddy's Laboratories
  • 18.11.1 Company Overview
  • 18.11.2 Company Snapshot
  • 18.11.3 Business Segments
  • 18.11.4 Business Performance
  • 18.11.5 Product Offerings
  • 18.11.6 Key Developmental Strategies
  • 18.11.7 SWOT Analysis
• 18.12 Sun Pharmaceutical Industries
  • 18.12.1 Company Overview
  • 18.12.2 Company Snapshot
  • 18.12.3 Business Segments
  • 18.12.4 Business Performance
  • 18.12.5 Product Offerings
  • 18.12.6 Key Developmental Strategies
  • 18.12.7 SWOT Analysis
• 18.13 Cipla
  • 18.13.1 Company Overview
  • 18.13.2 Company Snapshot
  • 18.13.3 Business Segments
  • 18.13.4 Business Performance
  • 18.13.5 Product Offerings
  • 18.13.6 Key Developmental Strategies
  • 18.13.7 SWOT Analysis
• 18.14 Aurobindo Pharma
  • 18.14.1 Company Overview
  • 18.14.2 Company Snapshot
  • 18.14.3 Business Segments
  • 18.14.4 Business Performance
  • 18.14.5 Product Offerings
  • 18.14.6 Key Developmental Strategies
  • 18.14.7 SWOT Analysis
• 18.15 Glenmark Pharmaceuticals
  • 18.15.1 Company Overview
  • 18.15.2 Company Snapshot
  • 18.15.3 Business Segments
  • 18.15.4 Business Performance
  • 18.15.5 Product Offerings
  • 18.15.6 Key Developmental Strategies
  • 18.15.7 SWOT Analysis
• 18.16 Alkem Laboratories
  • 18.16.1 Company Overview
  • 18.16.2 Company Snapshot
  • 18.16.3 Business Segments
  • 18.16.4 Business Performance
  • 18.16.5 Product Offerings
  • 18.16.6 Key Developmental Strategies
  • 18.16.7 SWOT Analysis
• 18.17 Biocon
  • 18.17.1 Company Overview
  • 18.17.2 Company Snapshot
  • 18.17.3 Business Segments
  • 18.17.4 Business Performance
  • 18.17.5 Product Offerings
  • 18.17.6 Key Developmental Strategies
  • 18.17.7 SWOT Analysis
• 18.18 Alnylam Pharmaceuticals
  • 18.18.1 Company Overview
  • 18.18.2 Company Snapshot
  • 18.18.3 Business Segments
  • 18.18.4 Business Performance
  • 18.18.5 Product Offerings
  • 18.18.6 Key Developmental Strategies
  • 18.18.7 SWOT Analysis
• 18.19 Arrowhead Pharmaceuticals
  • 18.19.1 Company Overview
  • 18.19.2 Company Snapshot
  • 18.19.3 Business Segments
  • 18.19.4 Business Performance
  • 18.19.5 Product Offerings
  • 18.19.6 Key Developmental Strategies
  • 18.19.7 SWOT Analysis
• 18.20 Ionis Pharmaceuticals
  • 18.20.1 Company Overview
  • 18.20.2 Company Snapshot
  • 18.20.3 Business Segments
  • 18.20.4 Business Performance
  • 18.20.5 Product Offerings
  • 18.20.6 Key Developmental Strategies
  • 18.20.7 SWOT Analysis

관련자료